Dr Judith Pratt

  • Honorary Associate Professor (Institute of Neuroscience & Psychology)

email: Judith.Pratt@glasgow.ac.uk

R306A Level 3, FBLS - Integrated Biology, West Medical Building

Publications

List by: Type | Date

Jump to: 2021 | 2020 | 2019 | 2014 | 2013 | 2012 | 2011 | 2010
Number of items: 12.

2021

Thomson, D. M., Mitchell, E. J., Openshaw, R. L., Pratt, J. A. and Morris, B. J. (2021) Mice lacking melatonin MT2 receptors exhibit attentional deficits, anxiety and enhanced social interaction. Journal of Psychopharmacology, (doi: 10.1177/02698811211032439) (PMID:34304635) (Early Online Publication)

Willis, A., Pratt, J. A. and Morris, B. J. (2021) BDNF and JNK signalling modulate cortical interneuron and perineuronal net development: implications for schizophrenia-linked 16p11.2 duplication syndrome. Schizophrenia Bulletin, 47(3), pp. 812-826. (doi: 10.1093/schbul/sbaa139) (PMID:33067994)

2020

Mitchell, E. J., Thomson, D. M., Openshaw, R. L., Bristow, G. C., Dawson, N., Pratt, J. A. and Morris, B. (2020) Drug-responsive autism phenotypes in the 16p11.2 deletion mouse model: a central role for gene-environment interactions. Scientific Reports, 10, 12303. (doi: 10.1038/s41598-020-69130-8) (PMID:32704009) (PMCID:PMC7378168)

Bristow, G. C., Thomson, D. M., Openshaw, R. L. , Mitchell, E. J., Pratt, J. A., Dawson, N. and Morris, B. J. (2020) 16p11 duplication disrupts hippocampal-orbitofrontal-amygdala connectivity, revealing a neural circuit endophenotype for schizophrenia. Cell Reports, 31(3), 107536. (doi: 10.1016/j.celrep.2020.107536) (PMID:32320645)

Openshaw, R., Thomson, D. M., Thompson, R., Penninger, J. M., Pratt, J. A., Morris, B. J. and Dawson, N. (2020) Map2k7 haploinsufficiency induces brain imaging endophenotypes and behavioral phenotypes relevant to schizophrenia. Schizophrenia Bulletin, 46(1), pp. 211-223. (doi: 10.1093/schbul/sbz044) (PMID:31219577) (PMCID:PMC6942167)

2019

Openshaw, R. L., Kwon, J., McColl, A., Penninger, J. M., Cavanagh, J. , Pratt, J. A. and Morris, B. J. (2019) JNK signalling mediates aspects of maternal immune activation: importance of maternal genotype in relation to schizophrenia risk. Journal of Neuroinflammation, 16(1), 18. (doi: 10.1186/s12974-019-1408-5) (PMID:30691477) (PMCID:PMC6350402)

2014

Winchester, C. L., Pratt, J. A. and Morris, B. J. (2014) Risk genes for schizophrenia: translational opportunities for drug discovery. Pharmacology and Therapeutics, 143(1), pp. 34-50. (doi: 10.1016/j.pharmthera.2014.02.003)

2013

Gilfillan, L., Blair, A., Morris, B. , Pratt, J., Schweiger, L., Pimlott, S. and Sutherland, A. (2013) Synthesis and biological evaluation of novel 2,3-dihydro-1H-1,5-benzodiazepin-2-ones; potential imaging agents of the metabotropic glutamate 2 receptor. MedChemComm, 4(7), pp. 1118-1123. (doi: 10.1039/c3md00110e)

2012

Steward, L.J., Kennedy, M.D., Morris, B.J. and Pratt, J.A. (2012) Chronic phencyclidine (PCP)-induced modulation of muscarinic receptor mRNAs in rat brain: Impact of antipsychotic drug treatment. Neuropharmacology, 62(3), pp. 1554-1563. (doi: 10.1016/j.neuropharm.2011.05.016)

2011

Xiao, X., Dawson, N., MacIntyre, L., Morris, B.J. , Pratt, J.A., Watson, D.G. and Higham, D.J. (2011) Exploring metabolic pathway disruption in the subchronic phencyclidine model of schizophrenia with the Generalized Singular Value Decomposition. BMC Systems Biology, 5(72), pp. 1-20. (doi: 10.1186/1752-0509-5-72)

2010

Dawson, N., Thompson, R.J., McVie, A., Thomson, D.M., Morris, B. J. and Pratt, J. A. (2010) Modafinil reverses phencyclidine-induced deficits in cognitive flexibility, cerebral metabolism, and functional brain connectivity. Schizophrenia Bulletin, 38(3), pp. 457-474. (doi: 10.1093/schbul/sbq090)

Thomson, D.M., McVie, A., Morris, B.J. and Pratt, J.A. (2010) Dissociation of acute and chronic intermittent phencyclidine-induced performance deficits in the 5-choice serial reaction time task: influence of clozapine. Psychopharmacology, 213(4), pp. 681-695. (doi: 10.1007/s00213-010-2020-7)

This list was generated on Thu Sep 16 08:35:24 2021 BST.
Jump to: Articles
Number of items: 12.

Articles

Thomson, D. M., Mitchell, E. J., Openshaw, R. L., Pratt, J. A. and Morris, B. J. (2021) Mice lacking melatonin MT2 receptors exhibit attentional deficits, anxiety and enhanced social interaction. Journal of Psychopharmacology, (doi: 10.1177/02698811211032439) (PMID:34304635) (Early Online Publication)

Willis, A., Pratt, J. A. and Morris, B. J. (2021) BDNF and JNK signalling modulate cortical interneuron and perineuronal net development: implications for schizophrenia-linked 16p11.2 duplication syndrome. Schizophrenia Bulletin, 47(3), pp. 812-826. (doi: 10.1093/schbul/sbaa139) (PMID:33067994)

Mitchell, E. J., Thomson, D. M., Openshaw, R. L., Bristow, G. C., Dawson, N., Pratt, J. A. and Morris, B. (2020) Drug-responsive autism phenotypes in the 16p11.2 deletion mouse model: a central role for gene-environment interactions. Scientific Reports, 10, 12303. (doi: 10.1038/s41598-020-69130-8) (PMID:32704009) (PMCID:PMC7378168)

Bristow, G. C., Thomson, D. M., Openshaw, R. L. , Mitchell, E. J., Pratt, J. A., Dawson, N. and Morris, B. J. (2020) 16p11 duplication disrupts hippocampal-orbitofrontal-amygdala connectivity, revealing a neural circuit endophenotype for schizophrenia. Cell Reports, 31(3), 107536. (doi: 10.1016/j.celrep.2020.107536) (PMID:32320645)

Openshaw, R., Thomson, D. M., Thompson, R., Penninger, J. M., Pratt, J. A., Morris, B. J. and Dawson, N. (2020) Map2k7 haploinsufficiency induces brain imaging endophenotypes and behavioral phenotypes relevant to schizophrenia. Schizophrenia Bulletin, 46(1), pp. 211-223. (doi: 10.1093/schbul/sbz044) (PMID:31219577) (PMCID:PMC6942167)

Openshaw, R. L., Kwon, J., McColl, A., Penninger, J. M., Cavanagh, J. , Pratt, J. A. and Morris, B. J. (2019) JNK signalling mediates aspects of maternal immune activation: importance of maternal genotype in relation to schizophrenia risk. Journal of Neuroinflammation, 16(1), 18. (doi: 10.1186/s12974-019-1408-5) (PMID:30691477) (PMCID:PMC6350402)

Winchester, C. L., Pratt, J. A. and Morris, B. J. (2014) Risk genes for schizophrenia: translational opportunities for drug discovery. Pharmacology and Therapeutics, 143(1), pp. 34-50. (doi: 10.1016/j.pharmthera.2014.02.003)

Gilfillan, L., Blair, A., Morris, B. , Pratt, J., Schweiger, L., Pimlott, S. and Sutherland, A. (2013) Synthesis and biological evaluation of novel 2,3-dihydro-1H-1,5-benzodiazepin-2-ones; potential imaging agents of the metabotropic glutamate 2 receptor. MedChemComm, 4(7), pp. 1118-1123. (doi: 10.1039/c3md00110e)

Steward, L.J., Kennedy, M.D., Morris, B.J. and Pratt, J.A. (2012) Chronic phencyclidine (PCP)-induced modulation of muscarinic receptor mRNAs in rat brain: Impact of antipsychotic drug treatment. Neuropharmacology, 62(3), pp. 1554-1563. (doi: 10.1016/j.neuropharm.2011.05.016)

Xiao, X., Dawson, N., MacIntyre, L., Morris, B.J. , Pratt, J.A., Watson, D.G. and Higham, D.J. (2011) Exploring metabolic pathway disruption in the subchronic phencyclidine model of schizophrenia with the Generalized Singular Value Decomposition. BMC Systems Biology, 5(72), pp. 1-20. (doi: 10.1186/1752-0509-5-72)

Dawson, N., Thompson, R.J., McVie, A., Thomson, D.M., Morris, B. J. and Pratt, J. A. (2010) Modafinil reverses phencyclidine-induced deficits in cognitive flexibility, cerebral metabolism, and functional brain connectivity. Schizophrenia Bulletin, 38(3), pp. 457-474. (doi: 10.1093/schbul/sbq090)

Thomson, D.M., McVie, A., Morris, B.J. and Pratt, J.A. (2010) Dissociation of acute and chronic intermittent phencyclidine-induced performance deficits in the 5-choice serial reaction time task: influence of clozapine. Psychopharmacology, 213(4), pp. 681-695. (doi: 10.1007/s00213-010-2020-7)

This list was generated on Thu Sep 16 08:35:24 2021 BST.